| Autor: |
Kotamarti S; Maimonides Medical Center, 745 64th St. 4th Floor, Brooklyn, NY, 11220, USA., Williams T; Hofstra-Northwell School of Medicine, 450 Lakeville Rd, Suite M42, Lake Success, NY, 11042, USA., Silver M; Maimonides Medical Center, 745 64th St. 4th Floor, Brooklyn, NY, 11220, USA.; 450 Clarkson Ave, BSB 4-32, Brooklyn, NY, 11203, USA., Silver DA; Maimonides Medical Center, 745 64th St. 4th Floor, Brooklyn, NY, 11220, USA., Schulman AA; Maimonides Medical Center, 745 64th St. 4th Floor, Brooklyn, NY, 11220, USA. Aschulman@maimonidesmed.org. |
| Abstrakt: |
Robotic-assisted laparoscopic prostatectomy (RALP) is the gold standard for the surgical management of localized prostate cancer (PCa). Multi-institutional series have demonstrated complications and readmissions in less than 5% of patients and most are now discharged within 24 h of surgery. Recently, several high-volume surgeons demonstrated the safety of same-day discharge (SDD) after RALP. The main benefits include lower costs and reduced exposure to nosocomial infections and hospital errors. The leading arguments for criticism include potential suboptimal postoperative care and the risk of missing a catastrophic event. In recent years, important advances have further strengthened the argument for SDD including more structured perioperative care, integration of single-port robotic systems, and new challenges presented by the coronavirus 2019 (COVID-19) pandemic. Here, we provide further evidence demonstrating the safety of SDD in a multi-institutional cohort of patients and review the main arguments supporting the expanded use of this approach. |
Full text from SpringerLink